卡尔蒂瓦:对最好的证据的回顾
Timothy Daniels1, Caroline Cristofaro1, Mansur Halai1
1Department of Orthopaedics, University of Toronto, Canada; Department of Orthopaedics, St Michael's Hospital, Toronto, Canada.
Foot and ankle clinics
|July 27, 2024
概括
卡尔蒂瓦植入物是一种合成软骨替代品,有效地治疗第一个关节关节关节炎和硬性疼痛. 它的目的是保护或恢复关节的运动范围,帮助外科医生在患者护理中.
科学领域:
- 整形外科手术 整形外科手术
- 生物材料科学是生物材料的科学.
- 足部医学 足部医学
背景情况:
- 第一个甲松关节关节炎,通常被称为硬化,引起显著的疼痛和有限的运动能力.
- 传统的治疗方法可能并不总能提供足够的缓解疼痛或保持关节功能.
- 卡尔蒂瓦植入物为软骨恢复提供了一种合成替代方案.
研究的目的:
- 审查Cartiva植入物用于治疗第一个甲状腺关节关节炎的结果.
- 分析观察到的结果背后的原因,并为外科医生提供技术珍珠.
- 巩固开创性和当前的证据,以指导外科手术决策和患者咨询.
主要方法:
- 关于Cartiva植入物的开创性文章和当前证据的文献综述.
- 分析患者的结果,包括缓解疼痛和运动范围.
- 确定影响结果的因素和常见的并发症.
主要成果:
- 卡尔蒂瓦植入物证明了对硬性的疼痛缓解的有效性.
- 保持或恢复运动范围是观察到的一个关键好处.
- 了解技术珍珠对于优化结果和管理潜在并发症至关重要.
结论:
- 卡尔蒂瓦植入物是一种可行的治疗选择,用于第一个甲状腺关节关节炎.
- 通过了解现有文献,外科医生可以优化患者的选择和结果.
- 适当的患者咨询和并发症管理对于成功使用Cartiva植入物至关重要.
相关概念视频
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.2K
01:28Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
152
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
152
01:16Bioequivalence: Overview
957
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
957